দেশ: যুক্তরাজ্য
ভাষা: ইংরেজি
সূত্র: VMD (Veterinary Medicines Directorate)
L Thyroxine Sodium
Dechra Limited
QH03AA01
L Thyroxine Sodium
Expired
Revised: March 2011 Amended pages SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF VETERINARY MEDICINAL PRODUCT Thyroxyl 0.2 mg Tablet. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: ACTIVE SUBSTANCE Levothyroxine Sodium 0.20 mg EXCIPIENTS Sunset Yellow FCF E110 0.1 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Small elliptical orange tablets. Scored on the face of each tablet with the strength in milligrams to the right. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the long term treatment of thyroid insufficiency in dogs. 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to the active ingredient. Do not use in animals suffering from thyrotoxicosis or uncorrected adrenal insufficiency. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE i. Special precautions for use in animals Appropriate laboratory tests should be conducted to confirm the diagnosis and ensure correct dosage. Page 1 of 5 Revised: March 2011 Amended pages Caution should be exercised in the treatment of dogs with clinically significant cardiac disease, hypertension or any disease rendering the animal susceptible to sharply increased metabolic rate. In such cases, consideration should be given to reducing the starting dose, increasing the dose at intervals whilst monitoring all clinical signs. Dogs with concurrent hypoadrenocorticism should be stabilised with appropriate steroid therapy before commencing treatment with levothyroxine sodium. The effects of thyroxine therapy are slow in being manifested. ii. Special precautions to be taken by the person administering the veterinary medicinal product to animals In case of acc সম্পূর্ণ নথি পড়ুন